In this work, synthesis, characterization and photophysical properties of trivalent rare earth complexes with a nonsteroidal anti-inflammatory drug [the indomethacinate (indo), presenting formulas RE(indo) 3 (H 2 O) x (x = 3, for Eu 3+ and Gd 3+ , and x = 4 for Tb 3+ ), RE(indo) 3 (bipy) and RE(indo) 3 (phen) (bipy: 2,2'-bipyridine, and phen: 1,10-phenanthroline)] were investigated. Based on photoluminescent results, the intramolecular energy transfer process from T 1 triplet states of indo, phen and bipy ligands to the 5 D 0 emitting level of the Eu 3+ ion in the coordination compounds is discussed. Accordingly, it is proposed two possible intramolecular energy transfer mechanisms between indomethacinate ligand and rare earth ions, which involve the participation of excited electronic states of the heterocyclic ligands as intermediate ones.
Introduction
In recent decades, metallotherapeutic drugs based on transition metal and trivalent rare earth ions have attracted considerable attention owing to their potential applications in medicine as anti-inflammatory, 1 antitumor, 2 antiproliferative, 3 antifungal, 4,5 antiviral 6,7 and antimicrobial. 8 Many of these compounds present enhanced biomedical activity, reduced toxicity 1 and diminished collateral effects as compared with non-coordinated parent drugs. Among various classes of metallotherapeutic drugs, those based on the nonsteroidal anti-inflammatory drugs (NSAIDs) from the carboxylate or oxicam families have received particular attention because of their great ability to coordinate to different metal ions, resulting thermodynamically and kinetically stable complexes.
The molecular structures of NSAIDs are characterized by the presence of chromophore groups and low-lying triplet state with energy in the range of 20,000-25,000 cm -1 , which may act as luminescent sensitizers for trivalent rare earth ions. 9 Additionally, molecules of NSAIDs may act as multidentate ligands for RE 3+ ion through their hard N-and O-sites. It is well-known that RE 3+ ions play a wide range of roles in fluoroimmunoassay methods, 10 therapy 11 and as luminescent probe for biomolecules 12 due to their unique spectroscopic properties such as narrow emission bands, high luminescence intensities and the long lifetimes of the 2S+1 L J emitting levels. Furthermore, the rare earth ions may be indirectly excited via coordinated ligand (antenna effect) in a spectral region far from those where emission is generally monitored.
Recently, Zhou et al. 13 have investigated the structural and photophysical properties of two new rare earth complexes where carprofen has acted as effective luminescence Rare Earth-Indomethacinate Complexes with Heterocyclic Ligands J. Braz. Chem. Soc. 2282 sensitizer for the Tb 3+ ion, but not for the Eu 3+ ion. Luminescence properties of the Tb 3+ complexes with ibuprofen and orthofen containing additional organic bases were also studied by Teslyuk et al. 9 in order to propose an analytical method to determine NSAID drugs. The chemiluminescent method, based on Eu 3+ emission for the determination of naproxen in pharmaceutical and urine, has been developed by Kaczmarek. 14 A m o n g N S A I D d r u g s , i n d o m e t h a c i n (1-(4-chlorobenzoyl)-5-methoxy-2-methyl-1H-indole-3-acetic acid (Hindo)) ( Figure 1 ) is considered one of the most clinically investigated. 1 Its coordination complexes with transition metals have been extensively investigated in terms of structural and spectroscopic properties. 15 Generally, these complexes present other donor ligands because indomethacinate (indo) cannot saturate the coordination sphere of the metal ions. In the case of the rare earth complexes, neutral ligands such as heteroaromatic and phosphine oxide ligands have been not only used for this purpose, but have been shown that they may also play an essential role in the luminescence sensitization that involves either a direct intramolecular energy transfer to the metal ion or an indirect mechanism via energy transfer to other ligands. The main evidences for this latter mechanism were reported for Eu 3+ -tris(diketonate) complexes, [16] [17] [18] however, the interligand energy transfer in rare earth complexes is still not clear.
In particular, excited triplet states of some heteroaromatic ligands are almost resonant with that for indomethacinate (indo) ligand, consequently, these states may contribute to an operative interligand energy transfer in which the heteroaromatic ligands act as energy acceptor from ionic ligands and, subsequently, transfer their energy to the trivalent rare earth ion increasing the luminescence intensity. Thus, the investigation of this intramolecular energy process may contribute to design of new highly luminescent complexes based on carboxylate ligands for different practical applications. Besides, up to now, to the best of our knowledge, no investigation has been carried out on the quantitative photophysical properties of the RE 3+ coordination compounds in the solid state containing indomethacin.
Herein, it is reported the synthesis, characterization, intramolecular ligand-to-metal energy transfer and photophysical properties study of the RE 3+ complexes (where RE 3+ : Eu 3+ , Gd 3+ or Tb 3+ ) with indomethacinate (indo) and ancillary heteroaromatic ligands (2,2'-bipyridine (bipy), and 1,10-phenanthroline (phen)), in the solid state. Photoluminescent properties of the Eu 3+ complexes have been thoroughly investigated taking into account the radiative (A rad ) and non-radiative (A nrad ) emission coefficients, experimental intensity parameters (Ω 2 and Ω 4 ) and emission quantum efficiency (η). Additionally, the synthesized complexes may be used to perform new methods for luminescence determination of NSAID drugs and potential application as target medicine.
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Experimental
Materials
The indomethacin ligand was extracted from the INDOCID ® drug using ethyl acetate as solvent and purified in a flash column chromatography on silica gel (Tedia, SiliaFlash ® F60 40-63 µm, 230-400 mesh), using a mixture of hexane and ethyl acetate (1:1) as eluent. The commercially available 2,2'-bipyridine (bipy) 99% and 1,10-phenanthroline (phen) monohydrated 99% heteroaromatic ligands were purchased from Sigma-Aldrich and were used without previous purification. The rare earth chlorides (RECl 3 •6H 2 O) were prepared by the reaction between their corresponding rare earth oxides, RE 2 ) and a heating rate of 10 °C min -1 were used as instrumental conditions. Steady-state luminescent spectra were acquired by using a Horiba JobinYvon Fluorolog-3 spectrofluorimeter presenting double grating 0.22 m monochromator (SPEX 1680) and a 450 W Xenon lamp as excitation source. Luminescence decay data were also collected by using a phosphorimeter SPEX 1934D accessory coupled to the Fluorolog-3 spectrofluorimeter.
Synthetic methodology
Synthesis of the RE(indo) 3 
Results and Discussion
Synthesis and characterization
Elemental analysis data of the rare earth indomethacinate complexes are in agreement with the ratios metal:indo:water and metal:indo:heteroaromatic equal to 1:3:3 for hydrated complexes (1 and 2), 1:3:4 for hydrated complex (3) and 1:3:1 for rare earth complexes (4-9) which contain bipy and phen as ancillary ligands.
FTIR spectrum for indomethacin ligand extracted from the INDOCID ® drug is in agreement ( Figure S1 in the Supplementary Information (SI) section). Figure 2 shows the FTIR spectra for the Eu 3+ -indomethacinate complexes, while FTIR spectra for Gd 3+ and Tb 3+ are presented in Figures S2 and S3 in the SI section. In general, the absorption spectra for the RE 3+ complexes (1-3) exhibit a broad band in the range of 2600-3400 cm -1 that is assigned to the O-H stretching of the water molecules. As can be seen, this band is not present in the vibrational spectra for the complexes containing the heteroaromatic ancillary ligands, indicating that water molecules have been substituted by neutral ligands. The characteristic absorption bands assigned to the carboxylic group (COOH) of the Hindo free ligand, e.g., n(O-H) at 3300 cm -1 and n(C=O) at 1734 cm -1 , have been substituted by the intense absorption bands assigned to n as (COO) (at 1613 cm for all the complexes (1-9), indicating that indo ligand is coordinated to the RE 3+ as chelating or bridging mode.
21-23
These results strongly suggest that those complexes are either binuclear or coordination polymers. Moreover, the absorption bands around 1468 and 1423 cm -1 indicate that bipy and phen heteroaromatic ligands are coordinated to the metal ions through their nitrogen atoms. 16, 24 The presence of water molecules in the complexes (1-3) was also characterized by thermogravimetric analysis. TGA curves (Figure 3 ) present a weight loss around 3.5% in the temperature interval between 60-150 o C that is attributed to the release of three water molecules for the complex (1) (similar to complex (2), see Figure S4 in the SI file). This result is similar to the thermal decomposition for the Ce(indo) 3 (H 2 O) 3 complex reported in reference. 15 Figure 3 also displays the TGA curves for the Eu 3+ complexes (4 and 7) containing bipy and phen ligands.
TGA curves for other coordination compounds are shown in Figures S4 and S5 in the SI section. For the complex (3), TGA curve shows a weight loss around 5% in the same temperature interval that is attributed to the release of four water molecules which corroborate with the CHN elemental analysis data. The resulting anhydrous compounds undergo thermal decomposition in successive steps that occur from 230 to 670 o C. In contrast to the hydrated complexes, TGA curves for the complexes (4) to (9) do not exhibit any weight loss until 150 o C, confirming the anhydrous form of these coordination compounds.
The coordination compounds (3, 6 and 9) present successive steps that take place in the range of 300-750 o C, starting with a weight loss that corresponds to the release of the phen ligand. The TGA curves show that complexes with bipy ligand (2, 5 and 8) are less stable than those ones containing phen ligand (3, 6 and 9). The first weight loss of these complexes (around 170 o C) may be assigned to the release of the bipy ligand. However, no well-defined level is observed in the TGA curves owing to the subsequent decomposition of the RE(indo) 3 products. The final products remain stable until 900 o C for the thermal decomposition of all complexes, which can be assigned to the corresponding rare earth oxide, RE 2 O 3 (RE: Eu and Gd) and Tb 4 O 7 .
Phosphorescent behavior
The emission spectra of the Gd 3+ complexes (2, 5 and 8) were recorded with excitation on the S 0 → S 1 12, 2017 indomethacinate centered transition at 350 nm (Figure 4) , showing two overlapped broad bands with maxima around 420 (blue region) and 500 nm (green region) assigned to the fluorescence (S 1 → S 0 ) and phosphorescence (T → S 1 ) intraligand transitions, respectively.
Since the highest intensity band is that due to the phosphorescence, the Gd 3+ -indomethacinate complexes present green emission color under UV radiation excitation. Interestingly, no obvious difference between the emission spectra profiles of the Gd 3+ complexes (5 and 8) and that for the precursor complex, 2, is observed, indicating that photoluminescence properties of all the Gd 3+ complexes are mainly due to the indomethacinate ligand coordinated to the RE 3+ ion. For these coordination compounds, the indomethacinate triplet state (T 1 ) was determined taking into account the 0-0 phonon transition from the timeresolved phosphorescence spectra recorded with time delay of 0.04 ms ( Figure S6 in the SI section) .
The absence of the short-lived fluorescence emission band around 420 nm in those spectra (Figure 4 ) allowed for a more precise determination of the T 1 state energies, as following: 22,124, 21,882 and 21,552 cm -1 for the Gd(indo) 3 (H 2 O) 3 (2), Gd(indo) 3 (bipy) (5) and Gd(indo) 3 (phen) (8) complexes, respectively. These optical data indicate that triplet states of indo ligand should be in a good resonance condition of the emitting levels of the Eu 3+ ion, acting as an efficient antenna for europium complexes. 16 Luminescence spectra of the Eu
3+
As to the emission monitored on the intraconfigurational 5 D 0 → 7 F 2 hypersensitive transition centered on the Eu 3+ ion (at approximately 612 nm), all excitation spectra for solid-state of the complexes (1, 4 and 7) exhibit similar spectral profiles. These spectra ( Figure 5 ) present a strong broad band in the range of 250-450 nm assigned to the S 0 → S 1 transition belong to indo ligand, indicating that even in the complexes with bipy and phen, the luminescence sensitization mechanism of the Eu 3+ ion started with radiation absorption by indomethacinate ligand. However, minor contributions due to the absorption from heterocyclic ligands are observed. It is worth noting that this band exhibits higher intensity than those ones from the intraconfigurational 7 F 0 → 2S+1 L J transitions at around 468 and 525 nm, confirming the potential ability of the ligand to transfer energy to the Eu 3+ ion.
The emission spectra of all the RE 3+ coordination compounds were recorded at 298 and 77 K, upon excitation on the ligand S 0 → S 1 transition (at 350 nm) of the indomethacinate ligand ( Figure 6 ). Under this condition, all the Eu 3+ -indomethacinate coordination compounds (1, 4 and 7) display high red luminescence at 77 K. A qualitative analysis shows that the Eu 3+ complexes with ancillary heteroaromatic ligands (4 and 7) exhibit significantly higher luminescent intensities than the hydrated complex (1).
The emission spectra of the complex (1) in the range of 430-720 nm recorded at 298 and 77 K exhibit different spectral profiles (Figure 6) . When recorded at 298 K, a broad band arising from intraligand transition is observed, that is only partially quenched in the emission spectrum recorded at 77 K. This band overlaps the standard set of well-resolved narrow emission bands owing to the Eu 3+ centered transitions: 5 24 On the other hand, one of the main features to be outlined from the photoluminescent spectra for complexes 4 and 7, both recorded at 298 and 77 K, is the absence of the broad emission bands due to the indomethacinate fluorescence or phosphorescence. All of these photoluminescence spectra display similar spectral profile, in which only the intraconfigurational-4f 6 transitions are observed, being dominated by the well-characterized hypersensitive 5 -indomethacinate complexes can be divided into two mechanisms, which is shown in Figure 7 . 27, 28 For the first mechanism, indomethacinate ligand absorbs energy being excited to its S 1 states, and subsequently transfers this energy to the T 1 excited state belonging to heterocyclic ligand (Figure 7) . Therefore, this latter ligand undergoes energy transfer from the intraligand triplet state to 5 . By means of the second mechanism, indomethacinate ligand absorbs energy being excited to its singlet state S 1 , which undergoes intersystem crossing energy to the own T 1 state and transfers to the triplet excited level (T 1 ) of the heterocyclic ligand, followed by sensitization of the excited levels of the Eu 3+ ( Figure 7) . In order to give an insight into the proposed . Following the standard methodology described by Sá et al., 28 the photophysical properties of the Eu 3+ ion into the novel complexes were quantitatively investigated. The spectroscopic parameters (A rad ), JuddOfelt intensity parameters (Ω λ , λ = 2, 4 and 6) and emission quantum efficiency (η) were directly determined from the photophysical data.
The radiative rates (A rad ) of the Eu 3+ -indomethacinate complexes were determined taking into account the following equation:
27 (1) where, A 01 = 0.31 × 10 -11 η 3 σ 3 and A 0J is the radiative rates assigned to the intraconfigurational 5 D 0 → 7 F 1 and 5 D 0 → 7 F J (J = 2, 4 and 6) transitions, respectively. S 0J and σ 0J correspond, respectively, to the integrated intensities and barycenters of the intraconfigurational transitions. Each Judd-Ofelt intensity parameters (Ω λ , λ = 2, 4 and 6) of the Eu 3+ ion presents a direct correlation with the A 0J for a particular 5 D 0 → 7 F J transition, which is expressed by the well-known equation reported in our previous work. 29 Importantly, luminescence quantum efficiency (η) for the Eu 3+ -indomethacinate complexes was determined from the product η = A rad τ, where τ is the luminescence decay lifetime of the 5 D 0 emitting level. The values of τ were determined by the well-adjusted single-exponential luminescence decay curves of the Eu 3+ complexes upon excitation and emission monitored at 350 and 613 nm, respectively. The non-radiative rate, A nrad , was estimated from the difference between the value of A total (1/τ) and A rad value. Table 1 presents the spectroscopic parameters obtained for all three Eu 3+ -indomethacinate compounds at 298 and 77 K. As can be seen, the values of radiative rates for the complexes are comparable, indicating that no marked change occurs in the symmetry around the central metal ion when water molecules are substituted by the heterocyclic ligands or when the temperature is changed. On the other hand, a significant decrease in non-radiative rates (A nrad ) is observed when water molecules are replaced by those ligands, which is expected due to the ability of water molecules act as luminescence quenchers via multiphonon decay mechanism. 30 
Eu
3+ complex (1) presents a considerably high dependence of A nrad on the temperature in comparison with all of the other complexes investigated in this work (Table 1 ). This result suggests that there is the multi-phonon luminescent quenching effect, promoted by water molecules, and the additional luminescence quenching channel, probably a ligand-to-metal charge transfer state (LMCT). As a result, the luminescence quantum efficiency for the hydrated Eu The A nrad values of the complexes (4) and (7) are very low and practically independent of temperature. Although the low values of A rad as compared with the Eu 3+ -β-diketoante complexes reported in the literature, 30 which present values of A rad close to 1000 s -1 , suggest that the low values of A nrad contribute for the augment of emission quantum efficiency (η) in more than six times as compared with hydrated complex (1) ( Table 1 Figure 8 shows the excitation spectra for Tb 3+ -indomethacinate complexes recorded at 77 K in the spectral range of 250-550 nm. These spectra exhibit broad absorption bands with maxima at around 350 nm and a sharp absorption band located at 480 nm that reflect the indirect (via ligand) and direct excitation of the Tb 3+ ion, respectively. The emission spectra of Tb 3+ -indomethacinate complexes were recorded at 298 and 77 K in the spectral range of 450-700 nm, under excitation on the intraligand S 0 → S 1 transition ( Figure 9 ). As shown in Figure 9a , all emission spectra measured at 298 K present a broad emission band due to the indomethacinate ligand that overlaps the sharp emission bands assigned to the intraconfiguration-4f Figure 10 . According to these results, the emission color of the Eu 3+ complex (1) is tunable from pink to red when temperature is lowed. This behavior reflects the complete quenching of the phosphorescence band from indomethacinate coordinated ligand for the emission spectrum recorded at 77 K. Besides, taking into consideration that the emission spectra of the Eu 3+ coordination compounds (4) and (7) recorded at both temperatures are dominated by the intraconfigurational-4f 6 narrow emission bands centered on the Eu 3+ ion, the CIE color coordinates are located in the red region of CIE chromaticity diagram, as expected. Thus, the europium complexes exhibit pure red emission color.
As mentioned above, all emission spectra of the Tb 3+ -indomethacinate compounds recorded at 298 K exhibit the high intense phosphorescence band assigned to T 1 → S 0 transition from indomethacinate ligand ( Figure  9a ). Therefore, they present CIE coordinates color in the green-yellow region. On the other hand, the green emission colors displayed by these complexes at 77 K reflect the dominating intensities of the narrow emission bands arising from the intraconfigurational-4f 8 -centered transition. This result suggests that RE-indomethacinate complexes are dinuclear or polymeric systems. Similar results were also observed for RE-ibuprofen complexes containing donor nitrogen ligands 36, 37 and for RE-dipivaloyl complexes with tppo as neutral ligand.
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Conclusions
Herein, nine novel rare earth indomethacinate complexes were successfully prepared using simple synthetic routes. The coordination compounds presenting formulas RE(indo) 3 (H 2 O) x , RE(indo) 3 (bipy) and RE(indo) 3 (phen) (RE: Eu 3+ , Gd 3+ and Tb 3+ , indo: indomethacinate ligand, bipy: 2,2'-bipyridine, and phen: 1,10-phenanthroline, x = 3 for Eu 3+ and Gd 3+ complexes, and x = 4 for Tb 3+ complex) were characterized by elemental analysis of C, N and H, thermogravimetric analysis and infrared spectroscopic data. Based on photoluminescent parameters, non-radiative rates (A nrad ) were drastically decreased when water molecules were substituted by heterocyclic ligands, which improved significantly the emission quantum efficiencies of the complexes. On the other hand, the radiative rates (A rad ) and the Judd-Ofelt Ω λ = 2, 4 parameters were almost insensitive to the coordination changes.
Referring to the coordination of heterocyclic ligands, the intramolecular energy transfer processes in the RE 3+ coordination compounds were also improved. The spectroscopic results indicated that T 1 excited states of the heterocyclic ligands play an important role as an intermediate state on the luminescence sensitization of the Eu 3+ ion by the indomethacinate ligand. Finally, the properties of RE 3+ -indomethacinate complexes in the solid state described in this work are highly appropriate for light conversion molecular devices, such as those used as luminescent markers for bioassays and bioimage fields.
Supplementary Information
FTIR spectra, thermogravimetric data and luminescence spectra for compounds 2, 5, 8, 3, 6 and 9 are available free of charge at http://jbcs.sbq.org.br as PDF file.
